Time to first and sustained improvement in WOMAC domains among patients with osteoarthritis receiving tanezumab
{{output}}
Objective: To assess onset of effect in three placebo- or nonsteroidal anti-inflammatory drug (NSAID)-controlled trials of tanezumab in patients with moderate-to-severe osteoarthritis. ... ...
